DXJ:NYE-WisdomTree Japan Hedged Equity Fund (USD)

ETF | Japan Stock |

Last Closing

USD 107.79

Change

+1.54 (+1.45)%

Market Cap

N/A

Volume

1.18M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

-0.15 (-0.49%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

+1.03 (+1.44%)

USD 0.44B
FLJH Franklin FTSE Japan Hedged ETF

+0.49 (+1.61%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

-1.16 (-1.43%)

N/A
EWJ iShares MSCI Japan ETF

-0.41 (-0.57%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

-0.22 (-0.55%)

N/A
HEWJ iShares Currency Hedged MSCI J..

+0.60 (+1.46%)

N/A
JPXN iShares JPX-Nikkei 400 ETF

-0.55 (-0.72%)

N/A
SCJ iShares MSCI Japan Small-Cap E..

-1.15 (-1.46%)

N/A

ETFs Containing DXJ

XNAV FundX Aggressive ETF 7.46 % 0.00 %

+0.29 (+0.43%)

N/A
GTAA 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.52% 100% F 83% B
Dividend Return 1.09% 60% D- 21% F
Total Return 23.61% 100% F 82% B
Trailing 12 Months  
Capital Gain 28.55% 100% F 69% C-
Dividend Return 3.06% 80% B- 42% F
Total Return 31.61% 100% F 68% D+
Trailing 5 Years  
Capital Gain 116.88% 100% F 87% B+
Dividend Return 19.36% 70% C- 66% D+
Total Return 136.24% 100% F 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 20.65% N/A N/A 83% B
Dividend Return 23.81% N/A N/A 83% B
Total Return 3.16% N/A N/A 62% D
Risk Return Profile  
Volatility (Standard Deviation) 16.67% N/A N/A 60% D-
Risk Adjusted Return 142.81% N/A N/A 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike